Johannesburg - Delayed Quote ZAc

Ascendis Health Limited (ASC.JO)

Compare
85.00
0.00
(0.00%)
As of January 29 at 5:00:20 PM GMT+2. Market Open.
Currency in ZAR All numbers in thousands
Download
Breakdown
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Total Revenue
1,535,437.00
1,535,437.00
1,559,458.00
1,825,469.00
2,203,027.00
Cost of Revenue
930,906.00
930,906.00
921,724.00
1,132,157.00
1,356,871.00
Gross Profit
604,531.00
604,531.00
637,734.00
693,312.00
846,156.00
Operating Expense
802,027.00
802,027.00
824,162.00
1,136,876.00
1,058,275.00
Operating Income
-197,496.00
-197,496.00
-186,428.00
-443,564.00
-212,119.00
Net Non Operating Interest Income Expense
-41,395.00
-41,395.00
-455,288.00
-1,054,204.00
-785,283.00
Pretax Income
-284,607.00
-284,607.00
-795,392.00
-1,546,188.00
-1,684,612.00
Tax Provision
1,635.00
1,635.00
-37,303.00
108,678.00
-122,947.00
Net Income Common Stockholders
75,322.00
75,322.00
449,200.00
-1,090,804.00
-965,808.00
Diluted NI Available to Com Stockholders
75,322.00
75,322.00
449,200.00
-1,090,804.00
-965,808.00
Basic EPS
0.12
--
0.94
-2.24
-2.00
Diluted EPS
0.12
--
0.94
-2.24
-2.00
Basic Average Shares
606,241.39
--
479,808.96
487,448.07
483,419.77
Diluted Average Shares
606,241.39
--
479,808.96
487,448.07
483,419.77
Total Operating Income as Reported
-226,008.00
-226,008.00
-317,442.00
-466,664.00
-896,288.00
Rent Expense Supplemental
17,204.00
17,204.00
22,662.00
26,313.00
--
Total Expenses
1,732,933.00
1,732,933.00
1,745,886.00
2,269,033.00
2,415,146.00
Net Income from Continuing & Discontinued Operation
75,322.00
75,322.00
449,200.00
-1,090,804.00
-965,808.00
Normalized Income
-250,261.03
-250,261.03
-596,402.78
-1,615,048.28
-864,420.83
Interest Income
6,335.00
6,335.00
4,383.00
3,519.00
4,255.00
Interest Expense
45,262.00
45,262.00
436,594.00
1,037,909.00
753,954.00
Net Interest Income
-41,395.00
-41,395.00
-455,288.00
-1,054,204.00
-785,283.00
EBIT
-239,345.00
-239,345.00
-358,798.00
-508,279.00
-930,658.00
EBITDA
-162,943.00
-162,943.00
-278,970.00
-422,999.00
-787,033.00
Reconciled Cost of Revenue
930,906.00
930,906.00
921,724.00
1,132,157.00
1,356,871.00
Reconciled Depreciation
76,402.00
76,402.00
79,828.00
85,280.00
143,625.00
Net Income from Continuing Operation Net Minority Interest
-286,242.00
-286,242.00
-759,035.00
-1,690,703.00
-1,512,408.00
Total Unusual Items Excluding Goodwill
-49,289.00
-49,289.00
-170,635.00
-105,076.00
-699,002.00
Total Unusual Items
-49,289.00
-49,289.00
-170,635.00
-105,076.00
-699,002.00
Normalized EBITDA
-113,654.00
-113,654.00
-108,335.00
-317,923.00
-88,031.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-13,308.03
-13,308.03
-8,002.78
-29,421.28
-51,014.83
6/30/2020 - 5/24/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

183490.KQ Enzychem Lifesciences Corporation
1,540.00
+2.67%
 
AIP.JO Adcock Ingram Holdings Limited
6,646.00
0.00%
 
AIHLF Adcock Ingram Holdings Limited
2.4500
0.00%
 
CCC.JO Cilo Cybin Holdings Ltd
420.00
+5.00%
 
TRUFF Red Light Holland Corp.
0.0320
+0.63%
 
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.7510
-5.53%
 
AKAN Akanda Corp.
1.6200
-9.50%
 
FLGC Flora Growth Corp.
0.7700
-2.56%
 
CGC Canopy Growth Corporation
2.0300
-3.79%
 
TLRY Tilray Brands, Inc.
1.0400
-4.59%